BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18772190)

  • 21. Herpesvirus entry mediator-Ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model.
    Pierer M; Schulz A; Rossol M; Kendzia E; Kyburz D; Haentzschel H; Baerwald C; Wagner U
    J Immunol; 2009 Mar; 182(5):3139-45. PubMed ID: 19234211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topoisomerase II inhibitors, irrespective of their chemical composition, ameliorate experimental arthritis.
    Verdrengh M; Isaksson O; Tarkowski A
    Rheumatology (Oxford); 2005 Feb; 44(2):183-6. PubMed ID: 15494349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints.
    Polzer K; Baeten D; Soleiman A; Distler J; Gerlag DM; Tak PP; Schett G; Zwerina J
    Ann Rheum Dis; 2008 Nov; 67(11):1610-6. PubMed ID: 18174217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation.
    Nandakumar KS; Bajtner E; Hill L; Böhm B; Rowley MJ; Burkhardt H; Holmdahl R
    Arthritis Rheum; 2008 Jan; 58(1):184-96. PubMed ID: 18163493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy.
    Briot K; Roux C; Gossec L; Charni N; Kolta S; Dougados M; Garnero P
    J Rheumatol; 2008 Feb; 35(2):310-4. PubMed ID: 18203315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
    Cañete JD; Suárez B; Hernández MV; Sanmartí R; Rego I; Celis R; Moll C; Pinto JA; Blanco FJ; Lozano F
    Ann Rheum Dis; 2009 Oct; 68(10):1547-52. PubMed ID: 18930989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors.
    Ballanti E; Perricone C; di Muzio G; Kroegler B; Chimenti MS; Graceffa D; Perricone R
    Autoimmun Rev; 2011 Aug; 10(10):617-23. PubMed ID: 21549221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade.
    Inglis JJ; Notley CA; Essex D; Wilson AW; Feldmann M; Anand P; Williams R
    Arthritis Rheum; 2007 Dec; 56(12):4015-23. PubMed ID: 18050216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genistein as an anti-inflammatory agent.
    Verdrengh M; Jonsson IM; Holmdahl R; Tarkowski A
    Inflamm Res; 2003 Aug; 52(8):341-6. PubMed ID: 14504672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human TNF-alpha gene vaccination prevents collagen-induced arthritis in mice.
    Shen Y; Chen J; Zhang X; Wu X; Xu Q
    Int Immunopharmacol; 2007 Sep; 7(9):1140-9. PubMed ID: 17630192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.
    Popa C; Netea MG; de Graaf J; van den Hoogen FH; Radstake TR; Toenhake-Dijkstra H; van Riel PL; van der Meer JW; Stalenhoef AF; Barrera P
    J Rheumatol; 2009 Apr; 36(4):724-30. PubMed ID: 19273452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease.
    Chen DY; Hsieh TY; Chen YM; Hsieh CW; Lan JL; Lin FJ
    Gerontology; 2009; 55(3):250-8. PubMed ID: 18849599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infliximab improves vascular stiffness in patients with rheumatoid arthritis.
    Wong M; Oakley SP; Young L; Jiang BY; Wierzbicki A; Panayi G; Chowienczyk P; Kirkham B
    Ann Rheum Dis; 2009 Aug; 68(8):1277-84. PubMed ID: 18930987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative status of DBA/1J mice with type II collagen-induced arthritis.
    Choi EM
    J Appl Toxicol; 2007; 27(5):472-81. PubMed ID: 17299831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
    Song X; Liang F; Liu N; Luo Y; Xue H; Yuan F; Tan L; Sun Y; Xi C; Xi Y
    Vaccine; 2009 Jan; 27(5):690-700. PubMed ID: 19095031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Madecassoside attenuates inflammatory response on collagen-induced arthritis in DBA/1 mice.
    Li H; Gong X; Zhang L; Zhang Z; Luo F; Zhou Q; Chen J; Wan J
    Phytomedicine; 2009 Jun; 16(6-7):538-46. PubMed ID: 19135346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis.
    Radovits BJ; Kievit W; Fransen J; van de Laar MA; Jansen TL; van Riel PL; Laan RF
    Ann Rheum Dis; 2009 Sep; 68(9):1470-3. PubMed ID: 19015210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis.
    Hasselberg A; Schön K; Tarkowski A; Lycke N
    Arthritis Rheum; 2009 Jun; 60(6):1672-82. PubMed ID: 19479868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.